ContributorsPublishersAdvertisers

Novel Targeted Therapies May Reduce Costs and Improve OS in Ovarian Cancer

cancernetwork.com
 2022-01-13

Cover picture for the articlePatients diagnosed with early-stage ovarian cancer who are treated with novel targeted therapies may experience better overall survival and less financial toxicity compared with those who have late stage disease. Utilizing novel targeted therapies such as olaparib (Lynparza) as a treatment for patients with newly diagnosed ovarian cancer may...

www.cancernetwork.com

Comments / 0

Comments / 0